rs147080359
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The ENST00000268638.10(IRF8):c.813C>T(p.Phe271=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00397 in 1,608,418 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0036 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 25 hom. )
Consequence
IRF8
ENST00000268638.10 synonymous
ENST00000268638.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.152
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 16-85918628-C-T is Benign according to our data. Variant chr16-85918628-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 542147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-85918628-C-T is described in Lovd as [Likely_benign]. Variant chr16-85918628-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.152 with no splicing effect.
BS2
High AC in GnomAd4 at 542 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF8 | NM_002163.4 | c.813C>T | p.Phe271= | synonymous_variant | 7/9 | ENST00000268638.10 | NP_002154.1 | |
IRF8 | NM_001363907.1 | c.843C>T | p.Phe281= | synonymous_variant | 7/9 | NP_001350836.1 | ||
IRF8 | NM_001363908.1 | c.201C>T | p.Phe67= | synonymous_variant | 5/7 | NP_001350837.1 | ||
IRF8 | XM_047434052.1 | c.843C>T | p.Phe281= | synonymous_variant | 8/10 | XP_047290008.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF8 | ENST00000268638.10 | c.813C>T | p.Phe271= | synonymous_variant | 7/9 | 1 | NM_002163.4 | ENSP00000268638 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00356 AC: 542AN: 152264Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
542
AN:
152264
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00340 AC: 813AN: 239020Hom.: 6 AF XY: 0.00328 AC XY: 431AN XY: 131354
GnomAD3 exomes
AF:
AC:
813
AN:
239020
Hom.:
AF XY:
AC XY:
431
AN XY:
131354
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00402 AC: 5850AN: 1456036Hom.: 25 Cov.: 31 AF XY: 0.00397 AC XY: 2876AN XY: 724628
GnomAD4 exome
AF:
AC:
5850
AN:
1456036
Hom.:
Cov.:
31
AF XY:
AC XY:
2876
AN XY:
724628
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00356 AC: 542AN: 152382Hom.: 2 Cov.: 33 AF XY: 0.00396 AC XY: 295AN XY: 74522
GnomAD4 genome
AF:
AC:
542
AN:
152382
Hom.:
Cov.:
33
AF XY:
AC XY:
295
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | IRF8: BP4, BP7, BS2 - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4016741:Immunodeficiency 32B Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at